Combining Checkpoint and Tyrosine Kinase Inhibitor in the Treatment of Renal Cell Carcinoma

被引：0
|
作者：
不详
机构：
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2020年 / 43卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：247 / 247
页数：1
相关论文
共 50 条
  • [31] Tyrosine kinase inhibitor treatment for renal cell carcinoma with inferior vena cava tumour thrombus: a quantitative summary
    Klatte, Tobias
    Welsh, Sarah J. J.
    Riddick, Antony C. P.
    Karam, Jose A.
    Stewart, Grant D. D.
    BJU INTERNATIONAL, 2023, 131 (05) : 566 - 568
  • [32] Reviewing Treatment Options for Advanced Renal Cell Carcinoma: Is There Still a Place for Tyrosine Kinase Inhibitor (TKI) Monotherapy?
    Mário Fontes-Sousa
    Helena Magalhães
    Alicia Oliveira
    Filipa Carneiro
    Filipa Palma dos Reis
    Pedro Silvestre Madeira
    Sara Meireles
    Advances in Therapy, 2022, 39 : 1107 - 1125
  • [33] Reviewing Treatment Options for Advanced Renal Cell Carcinoma: Is There Still a Place for Tyrosine Kinase Inhibitor (TKI) Monotherapy?
    Fontes-Sousa, Mario
    Magalhaes, Helena
    Oliveira, Alicia
    Carneiro, Filipa
    dos Reis, Filipa Palma
    Madeira, Pedro Silvestre
    Meireles, Sara
    ADVANCES IN THERAPY, 2022, 39 (03) : 1107 - 1125
  • [34] Application of extended immunotherapy in advanced clear cell renal cell carcinoma treated with first-line combination of immune-checkpoint inhibitor and tyrosine kinase inhibitor
    Wang, Qian
    Zhang, Xingming
    Zhu, Qiyu
    Zeng, Hong
    Dai, Jindong
    Chen, Junru
    Zhao, Jinge
    Sun, Guangxi
    Liu, Zhenhua
    Zeng, Hao
    Shen, Pengfei
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2024, : 1433 - 1440
  • [35] Novel role of a tyrosine kinase inhibitor by reversion of immune suppression in renal cell carcinoma
    Seliger, B.
    Mueller, A.
    Giersberg, Corinna
    Handke, Diana
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [36] Tyrosine Kinase Inhibitor Sunitinib Targets the Vasculature of Clear Cell Renal Cell Carcinoma: A Histological and Immunocytochemical Study of Treatment Effect
    Huang, J.
    Thomas, A.
    Simmerman, K.
    Sercia, L.
    Magi-Galluzzi, C.
    Campbell, S.
    Rini, B.
    Zhou, M.
    MODERN PATHOLOGY, 2010, 23 : 197A - 197A
  • [37] Tyrosine Kinase Inhibitor Sunitinib Targets the Vasculature of Clear Cell Renal Cell Carcinoma: A Histological and Immunocytochemical Study of Treatment Effect
    Huang, J.
    Thomas, A.
    Simmerman, K.
    Sercia, L.
    Magi-Galluzzi, C.
    Campbell, S.
    Rini, B.
    Zhou, M.
    LABORATORY INVESTIGATION, 2010, 90 : 197A - 197A
  • [38] Sequencing checkpoint inhibitor therapy in renal cell carcinoma
    Beckermann, Kathryn E.
    Rini, Brian
    LANCET, 2023, 402 (10397): : 160 - 161
  • [39] OUTCOME CHANGE IN PATIENTS WITH ADVANCED RENAL CELL CARCINOMA OUTSIDE OF CLINICAL TRIALS FROM THE TYROSINE-KINASE INHIBITOR ERA TO THE IMMUNE CHECKPOINT INHIBITOR ERA
    Ishihara, Hiroki
    Nemoto, Yuki
    Nakamura, Kazutaka
    Tachibana, Hidekazu
    Fukuda, Hironori
    Yoshida, Kazuhiko
    Kobayashi, Hirohito
    Iizuka, Junpei
    Shimmura, Hiroaki
    Hashimoto, Yasunobu
    Kondo, Tsunenori
    Takagi, Toshio
    JOURNAL OF UROLOGY, 2023, 209 : E373 - E373
  • [40] Tyrosine Kinase Inhibitors in Advanced Renal Cell Carcinoma: The Evolving Treatment Paradigm
    Bukowski, Ronald M.
    CLINICAL GENITOURINARY CANCER, 2009, 7 (01) : 9 - 10
12345